+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine



Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine



Biological Psychiatry 25(7): 962-965




(PDF emailed within 0-6 h: $19.90)

Accession: 033120076

Download citation: RISBibTeXText

PMID: 2720007

DOI: 10.1016/0006-3223(89)90275-8



Related references

Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. Journal of Nervous and Mental Disease 172(11): 692-695, 1984

Amantadine in malignant neuroleptic syndrome. Harefuah 100(7): 333-333, 1981

Amantadine in the neuroleptic malignant syndrome. Journal of Clinical Psychiatry 45(12): 526-526, 1984

Amantadine in neuroleptic malignant syndrome. Postgraduate Medical Journal 63(740): 508-509, 1987

Amantadine withdrawal and neuroleptic malignant syndrome. Neurology 43(10): 2155-2155, 1993

Neuroleptic malignant syndrome and amantadine withdrawal. American Journal of Psychiatry 142(1): 142-142, 1985

Neuroleptic malignant syndrome. A case associated with amantadine withdrawal. Medicina Clinica 85(15): 643-644, 1985

Successful use of amantadine in treatment of malignant neuroleptic syndrome. Psychiatrische Praxis 24(5): 257-258, 1998

A case of neuroleptic malignant syndrome successfully treated with amantadine. Journal of Clinical Psychiatry 43(9): 381-382, 1982

Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. American Journal of Psychiatry 141(6): 796-797, 1984

Neuroleptic malignant syndrome following withdrawal of amantadine in a patient with influenza A encephalopathy. European Journal of Pediatrics 160(6): 401, 2001

Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy. Comprehensive Psychiatry 27(4): 272-275, 1986

Haloperidol in neuroleptic malignant syndrome. American Journal of Psychiatry 145(5): 653-654, 1988

Haloperidol: neuroleptic malignant syndrome. New Zealand Medical Journal 95(704): 199-199, 1982